Zomedica Pharmaceuticals Stock Forecast - 8 Period Moving Average

ZOM Stock  USD 0.13  0.01  8.33%   
The 8 Period Moving Average forecasted value of Zomedica Pharmaceuticals Corp on the next trading day is expected to be 0.13 with a mean absolute deviation of  0.01  and the sum of the absolute errors of 0.31. Zomedica Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Zomedica Pharmaceuticals stock prices and determine the direction of Zomedica Pharmaceuticals Corp's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Zomedica Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Zomedica Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Zomedica Pharmaceuticals' systematic risk associated with finding meaningful patterns of Zomedica Pharmaceuticals fundamentals over time.
Check out Historical Fundamental Analysis of Zomedica Pharmaceuticals to cross-verify your projections.
  
At this time, Zomedica Pharmaceuticals' Payables Turnover is very stable compared to the past year. As of the 23rd of April 2024, Fixed Asset Turnover is likely to grow to 1.73, while Inventory Turnover is likely to drop 1.02. . As of the 23rd of April 2024, Common Stock Shares Outstanding is likely to grow to about 1 B, while Net Loss is likely to drop (16.1 M).
Most investors in Zomedica Pharmaceuticals cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Zomedica Pharmaceuticals' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Zomedica Pharmaceuticals' price structures and extracts relationships that further increase the generated results' accuracy.
An 8-period moving average forecast model for Zomedica Pharmaceuticals is based on an artificially constructed time series of Zomedica Pharmaceuticals daily prices in which the value for a trading day is replaced by the mean of that value and the values for 8 of preceding and succeeding time periods. This model is best suited for price series data that changes over time.

Zomedica Pharmaceuticals 8 Period Moving Average Price Forecast For the 24th of April

Given 90 days horizon, the 8 Period Moving Average forecasted value of Zomedica Pharmaceuticals Corp on the next trading day is expected to be 0.13 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.000067, and the sum of the absolute errors of 0.31.
Please note that although there have been many attempts to predict Zomedica Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Zomedica Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Zomedica Pharmaceuticals Stock Forecast Pattern

Backtest Zomedica PharmaceuticalsZomedica Pharmaceuticals Price PredictionBuy or Sell Advice 

Zomedica Pharmaceuticals Forecasted Value

In the context of forecasting Zomedica Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Zomedica Pharmaceuticals' downside and upside margins for the forecasting period are 0 and 5.90, respectively. We have considered Zomedica Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.13
0.13
Expected Value
5.90
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the 8 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Zomedica Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Zomedica Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria93.7933
BiasArithmetic mean of the errors 1.0E-4
MADMean absolute deviation0.0059
MAPEMean absolute percentage error0.0434
SAESum of the absolute errors0.3113
The eieght-period moving average method has an advantage over other forecasting models in that it does smooth out peaks and valleys in a set of daily observations. Zomedica Pharmaceuticals Corp 8-period moving average forecast can only be used reliably to predict one or two periods into the future.

Predictive Modules for Zomedica Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Zomedica Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Zomedica Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.010.135.89
Details
Intrinsic
Valuation
LowRealHigh
0.081.597.35
Details
0 Analysts
Consensus
LowTargetHigh
5.466.006.66
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.0025-0.0025-0.0025
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Zomedica Pharmaceuticals. Your research has to be compared to or analyzed against Zomedica Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Zomedica Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Zomedica Pharmaceuticals.

Other Forecasting Options for Zomedica Pharmaceuticals

For every potential investor in Zomedica, whether a beginner or expert, Zomedica Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Zomedica Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Zomedica. Basic forecasting techniques help filter out the noise by identifying Zomedica Pharmaceuticals' price trends.

Zomedica Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Zomedica Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Zomedica Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Zomedica Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Zomedica Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Zomedica Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Zomedica Pharmaceuticals' current price.

Zomedica Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Zomedica Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zomedica Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Zomedica Pharmaceuticals stock market strength indicators, traders can identify Zomedica Pharmaceuticals Corp entry and exit signals to maximize returns.

Zomedica Pharmaceuticals Risk Indicators

The analysis of Zomedica Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Zomedica Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting zomedica stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Zomedica Pharmaceuticals is a strong investment it is important to analyze Zomedica Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zomedica Pharmaceuticals' future performance. For an informed investment choice regarding Zomedica Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Zomedica Pharmaceuticals to cross-verify your projections.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for Zomedica Stock analysis

When running Zomedica Pharmaceuticals' price analysis, check to measure Zomedica Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zomedica Pharmaceuticals is operating at the current time. Most of Zomedica Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Zomedica Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zomedica Pharmaceuticals' price. Additionally, you may evaluate how the addition of Zomedica Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Is Zomedica Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zomedica Pharmaceuticals. If investors know Zomedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zomedica Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.03)
Revenue Per Share
0.026
Quarterly Revenue Growth
0.192
Return On Assets
(0.07)
Return On Equity
(0.14)
The market value of Zomedica Pharmaceuticals is measured differently than its book value, which is the value of Zomedica that is recorded on the company's balance sheet. Investors also form their own opinion of Zomedica Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Zomedica Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zomedica Pharmaceuticals' market value can be influenced by many factors that don't directly affect Zomedica Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zomedica Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zomedica Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zomedica Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.